Bone Health in Acromegaly
- PMID: 41130654
- DOI: 10.1016/j.ecl.2025.06.008
Bone Health in Acromegaly
Abstract
Skeletal fragility is a complication of acromegaly closely related to hypersecretion of growth hormone (GH) and insulin-like growth factor-1. In this condition, altered-bone remodeling causes deterioration of bone microstructure and impairment of bone strength, resulting in a high risk of vertebral fractures. The management of skeletal fragility in acromegaly might be a challenge since prediction of fractures is difficult, biochemical control of GH hypersecretion does not restore normal bone structure in most of patients, and the efficacy of bone-active drugs in this clinical context is unknown. This article deals with emerging pathophysiologic, clinical, and therapeutic aspects of acromegalic osteopathy.
Keywords: Acromegaly; Arthropathy; Bone; Osteopathy; Osteoporosis; Vertebral fractures.
Copyright © 2025 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure G. Mazziotti received fees for educational purposes from Amgen, United States/UCB, Belgium and Sanofi, United States and lecture fees from Theramex, United Kingdom, outside the submitted work. A. G. Lania received grants from Pfizer and lecture fees from Recordati, outside the submitted work. The other authors have nothing to declare.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
